Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Fluticasone recalled?

Yes — there is an active recall. 3 ongoing FDA recalls mention Fluticasone (22 total). Check the affected lots below.

Most common reason: Wrong potency / content (5 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Fluticasone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Fluticasone recalls on record

none so far in 2026; 22 on record, newest first
Class II · Moderate risk

Inhub Wixela

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0202-2024
Class II · Moderate risk

AirDuo Digihaler 55/14

Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Terminated Wrong potency / content Teva Pharmaceuticals USA NDC 59310-111-06 D-0023-2022
Class II · Moderate risk

Trelegy Ellipta

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0173-0887-10 D-0482-2021
Class II · Moderate risk

Trelegy Ellipta

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0481-2021
Class II · Moderate risk

Arnuity Ellipta

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0173-0876-10 D-0480-2021
Class II · Moderate risk

Fluticasone propionate USP

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8276-3 D-0539-2018
Class II · Moderate risk

Fluticasone Propionate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-690-2015
Class III · Low risk

Advair HFA

Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.

Terminated Stability / shelf life GlaxoSmithKline, LLC. NDC 0173-0715-22 D-065-2013
Class III · Low risk

Advair HFA

Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.

Terminated Stability / shelf life GlaxoSmithKline, LLC. NDC 0173-0715-20 D-064-2013